会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明专利
    • DD238981A5
    • 1986-09-10
    • DD28141585
    • 1985-10-03
    • BOEHRINGER INGELHEIM KG
    • ROOS OTTOSCHNORRENBERG GERDLOESEL WALTERWIEDEMANN INGRIDGAIDA WOLFRAMHOEFKE WOLFGANG
    • C07K14/81A61K38/00A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/068
    • The amino acid derivatives have the general formula in which R is H, acetyl, benzoyl, pivaloyl or the radical P is one of the numbers 1-4; A is a residue of one of the alpha -amino acids or R2 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2of the hetero atoms O, S or N, or R2 and R3 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or more of the hetero atoms O, S or N; R4 is OH, C1-C4- omega -hydroxyalkyl, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R5 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl, mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R6 is hydrogen or methyl; R7 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, NR8, CR9, CHR9, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two of the radicals X, Y and Z can be NR8; R8 is hydrogen or C1-C4-alkyl, straight-chain or branched; R9 is hydrogen or, together with a vicinal radical R9, a phenyl ring or, for m and n = 1, the dihydro form thereof with double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2. The compounds are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.
    • 7. 发明专利
    • PROCESS FOR PREPARING AMINO ACID-DERIVATIVES
    • HUT39192A
    • 1986-08-28
    • HU385485
    • 1985-10-04
    • BOEHRINGER INGELHEIM KG
    • ROOS OTTOLOESEL WALTERSCHNORRENBERG GERDWIEDEMANN INGRIDGAIDA WOLFRAMHOEFKE WOLFGANG
    • C07K14/81A61K38/00A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/068A61K37/02
    • The amino acid derivatives have the general formula in which R is H, acetyl, benzoyl, pivaloyl or the radical P is one of the numbers 1-4; A is a residue of one of the alpha -amino acids or R2 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2of the hetero atoms O, S or N, or R2 and R3 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or more of the hetero atoms O, S or N; R4 is OH, C1-C4- omega -hydroxyalkyl, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R5 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl, mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R6 is hydrogen or methyl; R7 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, NR8, CR9, CHR9, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two of the radicals X, Y and Z can be NR8; R8 is hydrogen or C1-C4-alkyl, straight-chain or branched; R9 is hydrogen or, together with a vicinal radical R9, a phenyl ring or, for m and n = 1, the dihydro form thereof with double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2. The compounds are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.
    • 8. 发明专利
    • DK454185D0
    • 1985-10-04
    • DK454185
    • 1985-10-04
    • BOEHRINGER INGELHEIM KG
    • ROOS OTTOSCHNORRENBERG GERDLOESEL WALTERWIEDEMANN INGRIDGAIDA WOLFRAMHOEFKE WOLFGANG
    • C07K14/81A61K38/00A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/068C07K
    • The amino acid derivatives have the general formula in which R is H, acetyl, benzoyl, pivaloyl or the radical P is one of the numbers 1-4; A is a residue of one of the alpha -amino acids or R2 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2of the hetero atoms O, S or N, or R2 and R3 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or more of the hetero atoms O, S or N; R4 is OH, C1-C4- omega -hydroxyalkyl, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R5 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl, mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R6 is hydrogen or methyl; R7 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, NR8, CR9, CHR9, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two of the radicals X, Y and Z can be NR8; R8 is hydrogen or C1-C4-alkyl, straight-chain or branched; R9 is hydrogen or, together with a vicinal radical R9, a phenyl ring or, for m and n = 1, the dihydro form thereof with double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2. The compounds are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.
    • 10. 发明专利
    • FI853354A0
    • 1985-09-02
    • FI853354
    • 1985-09-02
    • BOEHRINGER INGELHEIM KG
    • ROOS OTTOLOESEL WALTERSCHNORRENBERG GERDWIEDEMANN INGRIDGAIDA WOLFRAMHOEFKE WOLFGANG
    • C07D495/04A61K31/401A61K31/435A61K38/00A61K38/05A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/062C07K14/81C07K
    • The derivatives have the general formula in which R1 is H, phenyl, benzyl, phenethyl; R2 is H, acetyl, benzoyl, 3-sulphonamido-4-chlorobenzoyl, 3-sulphonamido-4-chloro-6-hydroxybenzoyl, 3-sulphonamido-4-chloro-5-[(furyl)amino]benzoyl, 2,3-dichloro-4-( beta -phenylacryloyl) phenoxyacetyl, pivaloyl, C1-C2-alkylaminocarbonyl, C1-C2-alkylaminothiocarbonyl, acyl or the radical A is the residue of one of the alpha -amino acids or R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R4 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, or R3 and R4 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or two more of the hetero atoms O, S or N; R5 is OH, C1-C4- omega -hydroxyalkoxy, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R6 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl,mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R7 is hydrogen or methyl; R8 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, CR10, CHR10, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two radicals X, Y and Z can be NR9; R9 is hydrogen or C1-C4-alkyl, straight-chain or branched; R10 is hydrogen or, together with a vicinal radical R10, a phenyl ring or, for m and n = 1, the dihydro form thereof with the double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2, and are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.